Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome

N Engl J Med. 2016 Mar 17;374(11):1094-5. doi: 10.1056/NEJMc1600140.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Peptides / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Peptides
  • Glucagon-Like Peptide-1 Receptor Agonists